RPRX
Royalty Pharma PlcNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$31.38B
P/E Ratio
28.68
EPS
$1.90
Beta
0.40
52W High
$54.63
52W Low
$31.53
50-Day MA
$49.13
200-Day MA
$41.70
Dividend Yield
1.67%
Profit Margin
33.90%
Forward P/E
45.05
PEG Ratio
2.04
About Royalty Pharma Plc
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.44B |
| Gross Profit (TTM) | $2.81B |
| EBITDA | $1.56B |
| Operating Margin | 100.30% |
| Return on Equity | 13.80% |
| Return on Assets | 5.54% |
| Revenue/Share (TTM) | $5.67 |
| Book Value | $15.11 |
| Price-to-Book | 3.51 |
| Price-to-Sales (TTM) | 12.86 |
| EV/Revenue | 13.0 |
| EV/EBITDA | 18.67 |
| Quarterly Earnings Growth (YoY) | 23.20% |
| Quarterly Revenue Growth (YoY) | 11.00% |
| Shares Outstanding | $443.27M |
| Float | $410.36M |
| % Insiders | 7.16% |
| % Institutions | 85.70% |
Historical Volatility
HV 10-Day
20.12%
HV 20-Day
17.55%
HV 30-Day
17.91%
HV 60-Day
21.60%
HV Rank
11.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($59.25 target)
2
Strong Buy6
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026